Cathepsin D as a prognostic marker in breast cancer
Asculai, E.; Gopas, J.; Cohen, Y.
Harefuah 130(11): 787-790
1996
ISSN/ISBN: 0017-7768 PMID: 8794687 Document Number: 467547
Document emailed within 1 workday
Related Documents
Golmohammadi, R.; Pejhan, A. 2012: The prognostic value of the P53 protein and the Ki67 marker in breast cancer patients Jpma. Journal of the Pakistan Medical Association 62(9): 871-875Silvestrini, R.; Daidone, M.G.; Valagussa, P.; Salvadori, B.; Rovini, D.; Bonadonna, G. 1987: Cell kinetics as a prognostic marker in locally advanced breast cancer Cancer Treatment Reports 71(4): 375-379
Schultz, D.C.; Bazel, S.; Wright, L.M.; Tucker, S.; Lange, M.K.; Tachovsky, T.; Longo, S.; Niedbala, S.; Alhadeff, J.A. 1994: Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls Cancer Research 54(1): 48-54
Hirano, T.; Yoshioka, H. 1993: Serum cathepsin B levels, urinary excretion of cathepsin B and tissue cathepsin B content in the patients with gastric cancer Nihon Geka Hokan. Archiv für Japanische Chirurgie 62(5): 217-221
Futyma, K.; Kubiatowski, T.; Rózyńska, K.; Zdunek, M.łg.; Kotarski, J.; Rechberger, T.; Wojcierowski, J. 2009: Decreased osteonectin and fibronectin gene expression in endometrial cancer cancer as a prognostic marker Ginekologia Polska 80(12): 907-913
Krepela, E.; Vicar, J.; Cernoch, M. 1989: Cathepsin B in human breast tumor tissue and cancer cells Neoplasma 36(1): 41-52
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 165-170
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 159-163
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Rajah, T.T.; Dunn, S.T.; Pento, J.T. 1996: The influence of antiestrogens on pS2 and cathepsin D mRNA induction in MCF-7 breast cancer cells Anticancer Research 16(2): 837-842
Dengler, R.; Lah, T.; Gabrijelcic, D.; Turk, V.; Fritz, H.; Emmerich, B. 1991: Detection of cathepsin B in tumor cytosol and urine of breast cancer patients Biomedica Biochimica Acta 50(4-6): 555-560
Marsigliante, S.; Mottaghi, A.; Muscella, A.; Ciardo, V.; Leo, G.; Storelli, C. 1995: Effect of tumor size on the association between ps2 and cathepsin-d in primary breast-cancer International Journal of Oncology 6(1): 69-73
Briozzo, P.; Morisset, M.; Capony, F.; Rougeot, C.; Rochefort, H. 1988: In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells Cancer Research 48(13): 3688-3692
Duffy, M.J.; Brouillet, J.P.; Reilly, D.; McDermott, E.; O'Higgins, N.; Fennelly, J.J.; Maudelonde, T.; Rochefort, H. 1991: Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings Clinical Chemistry 37(1): 101-104
Herszényi, L.; Plebani, M.; Carraro, P.; De Paoli, M.; Roveroni, G.; Rugge, M.; Cardin, R.; Naccarato, R.; Farinati, F. 1995: Role and behavior of cathepsin B and cathepsin L in gastric cancer Orvosi Hetilap 136(25): 1315-1318
Klarskov, L.; Engel, U.H.øj.; Mogensen, A.M.; Jensen, H.L.; Holck, S. 2009: Tumour-cell dissociation as a prognostic marker in colorectal cancer Ugeskrift for Laeger 171(39): 2812-2817
Penault-Llorca, F.; Jacquemier, J.; Le Doussal, V.; Voigt, J.J. 1999: Quality challenge for immunohistochemistry: example of the ERBB-2 status in breast cancer. Group for Evaluation of Prognostic Factors in Immunohistochemistry in Breast Cancer (GEFPICS) Annales de Pathologie 19(4): 280-282
Hu, H.; Li, C.; Cai, S.; Zhu, C.; Tian, Y.; Zheng, J.; Hu, J.; Chen, C.; Liu, W. 2014: Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer Hepato-Gastroenterology 61(133): 1478-1482
Okholm, C.; Thorsteinsson, M.; Achiam, M.P. 2014: Circulating tumour cells is a promising prognostic and predictive marker of gastric cancer Ugeskrift for Laeger 176(32): 1490-1493
Liu, F-Teng.; Zhu, P-Qian.; Luo, H-Liang.; Zhang, Y.; Hao, T-Fei.; Xia, G-Fei.; Zhu, Z-Ming.; Qiu, C. 2016: Long noncoding RNA ANRIL: a potential novel prognostic marker in cancer: a meta-analysis Minerva Medica 107(2): 77-83